🇺🇸 FDA
Pipeline program

A trial to learn how ceralasertib affects the way certain medications move throughout the body over time and how safe it is to use ceralasertib with these medications in adults with advanced solid tumors

D533BC00003

Phase 1 other active

Quick answer

A trial to learn how ceralasertib affects the way certain medications move throughout the body over time and how safe it is to use ceralasertib with these medications in adults with advanced solid tumors for Advanced solid tumour is a Phase 1 program (other) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).

Program details

Company
AstraZeneca AB
Indication
Advanced solid tumour
Phase
Phase 1
Modality
other
Status
active

Clinical trials